Cherubism: Clinicoradiographic Features and Treatment by Luiz Antonio Guimarães Cabral et al.
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                                                    Lima et al.
Cherubism: Clinicoradiographic Features and Treatment
Gabriela de Morais Gouvêa Lima1, Janete Dias Almeida2, Luiz Antonio Guimarães Cabral2
1Postgraduation Program in Oral Biopathology, São José dos Campos Dental School, São Paulo State University - UNESP, 
São José dos Campos, São Paulo, Brazil
2Department of Biosciences and Oral Diagnosis, São José dos Campos Dental School, São Paulo State University - UNESP, 
São José dos Campos, São Paulo, Brazil
Corresponding Author:
Gabriela de Morais Gouvêa Lima
Rua Engenheiro João Fonseca dos Santos, 158, apto. 13 B , Vl. Adyanna
CEP 12243-690, São José dos Campos, São Paulo,
Brazil
Phone: (12) 33075231
E-mail: gabrielademorais@yahoo.com.br
ABSTRACT
Objectives: Cherubism is a congenital childhood disease of autosomal dominant inheritance. This disease is characterized by 
painless bilateral enlargement of the jaws, in which bone is replaced with fibrous tissue. The condition has sui generis clinical, 
radiographic and histological features, of which the clinician should be aware for a better differential diagnosis in the presence 
of a fibro-osseous lesion affecting the bones of the maxillomandibular complex. The purpose of present paper was to review 
the literature and to report the most important aspects of cherubism in order to facilitate the study of this disease.
Material and Methods: Literature was reviewed about cherubism, emphasizing the relevant clinicoradiographic features and 
treatment. Literature was selected through a search of PubMed and Scielo electronic databases. The keywords used for search 
were adolescent, cherubism, cherubism/physiopathology, cherubism/treatment, cherubism/radiography. A manual search of 
the reference lists of the identified articles and the authors’ article files and recent reviews was conducted to identify additional 
publications. Those studies that described new features about cherubism were included in this review.
Results: In total 44 literature sources were obtained and reviewed. Studies that described new features about cherubism 
physiopathology, diagnostics and treatment were reviewed.
Conclusions: Despite the exceptions, cherubism is a clinically well-characterized disease. In cases of a suspicion of cherubism, 
radiographic examination is essential since the clinical presentation, the location and distribution of the lesions may define 
the diagnosis. Histopathological examination is complementary. Nowadays, genetic tests should be used for final diagnosis 
of cherubism.
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INTRODUCTION
Cherubism is a rare disease of autosomal dominant 
inheritance characterized by painless, frequently 
symmetrical, enlargement of the jaws as a result of the 
replacement of bone with fibrous tissue [1-16,20,29]. 
The disease is also called familial fibrous dysplasia of 
the jaws, but recent genetic investigation has shown 
it  to  be  a  separate  entity  at  the  molecular  level  [7]. 
Furthermore Lannon et al. [30] mentioned necessity to 
distinguish cherubism from central giant cell granuloma 
and giant cell tumour of the jaws, with which it holds a 
false synonymity.
A molecular pathogenesis of cherubism has been 
proposed, with the detection of a mutation in the gene 
encoding SH3 - binding protein 2 (SH3BP2) [6,10,31] 
and possible degradation of the Msx-1 gene which is 
involved in the regulation of mesenchymal interaction 
during craniofacial morphogenesis [11]. It is believed 
that the different clinical manifestations of cherubism 
are due to the changes secondary to mutations or 
incomplete penetrance [10]. 
Cherubism is usually diagnosed in children aged 2 to 
7  years,  with  the  observation  of  exacerbation  of  its 
manifestations within the first 2 years after diagnosis 
[5,32] and of stabilization or even regression after 
puberty [1-14,20]. Boys are more affected than girls at 
the proportion of  2 : 1 [3-6,14,33].
Clinically, cherubism is characterized by bilateral 
enlargement of the mandible and/or maxilla, causing 
a rounded face and swollen cheeks accompanied by 
upward-looking eyes. This condition gives the patient 
the appearance of cherubs depicted in baroque artwork 
[1,4-12,14,16,20,34]; hence, the name of the disease 
introduced by Jones [17], who published the first four 
cases affecting the same family. 
The purpose of the present paper was to review the 
literature and to report the most important aspects of 
cherubism in order to facilitate the study of this disease.
MATERIAL AND METHODS
Literature was reviewed about cherubism, 
emphasizing the relevant clinicoradiographic features, 
physiopathology and treatment. Literature was selected 
through a search of PubMed and Scielo electronic 
databases. The keywords used for search were 
adolescent, cherubism, cherubism/physiopathology, 
cherubism/treatment, cherubism/radiography. A manual 
search of the reference lists of the identified articles 
and the authors’ article files and recent reviews was 
conducted to identify additional publications. Those 
studies that described new features about cherubism 
physiopathology, diagnostics and treatment were 
included in this review.
RESULTS
Pathogenesis
Although rare, cherubism is part of the differential 
diagnosis of bone diseases affecting the 
maxillomandibular  complex  and  the  professionals 
should therefore have knowledge of the disease. The 
most accepted theory regarding the pathogenesis 
of cherubism is its association with an autosomal 
dominant  gene,  i.e.,  family  inheritance  [1-9,11-
17,23,35]. However, there are reports of the cases in 
which no criteria of heredity could be established [1-
3,9,11,12,15,16,24], or in which an autosomal recessive 
pattern of inheritance was suggested [5]. In addition 
to genetic factors, Caballero and Vinals [14] indicated 
other possible causes of cherubism such as mesenchymal 
alterations during jaw development, an odontogenic 
origin or even hormonal and traumatic factors. Today 
we know that a mutation in the gene encoding SH3BP2 
plays  a  role  in  the  disease  [6,7,10,11,21]. There are 
indications that the gene SH3BP2 plays a role in 
regulating the increased osteoblast and osteoclast 
activities that are seen in normal tooth eruption, and 
point mutations in the gene could cause pathologic 
activation  of  osteoclasts  [21,31,36].  Silva  et  al.  [11] 
reported  the  degradation  of  Msx-1  gene,  which  is 
involved in the regulation of mesenchymal interaction 
during craniofacial morphogenesis. In contrast, Sarda 
et al. [10] detected a point mutation at the SH3 binding 
site of the SH3BP2 gene, and Li and Yu [6] observed 
mutations in exon 9 of the same gene.
According to Hyckel et al. [26] cherubism is a location-
stable phenomenon found only in the jaws with multiple 
occurrences. Furthermore, structure-associated process 
is a very likely link to the pathogenic mechanism. The 
authors defined cherubism as a genetically determined 
alteration of tooth germ development. They proposed 
the molecular model of cherubism pathogenesis which 
is based on interaction between a disturbed (due to 
mutation in SH3BP2) parathyreoid hormone related 
protein  (PTHrP)  receptor  with  the  Hox  gene  Msx-
1 activity. Thus the temporal and spatial termination 
of  the  clinical  symptoms  is  explained  by  SH3BP2  - 
dependent signal transduction pathways interfering with 
jaw morphogenesis. The cap stage of the second and 
third molars, a spatial compartmentation does not take 
place, being necessary for normal dental development. 
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bone formation, and to the development of giant cell 
granulomas containing osteoclasts.
Clinical characteristics and symptoms
Patients with cherubism, generally males at a 
proportion of 2 : 1 [2,3,5,7,14], present the same clinical 
characteristics: enlarged face due to swelling of the 
jaws which is bilateral in most cases, bone consistency 
of the lesion, intact mucosa, dental malocclusion, 
upward-looking  eyes  in  the  case  of  maxillary 
involvement,  and  absence  of  pain  [2,4-9,11,12,14-
17,37]. The concomitant presence of cervical and/or 
submandibular lymphadenopathy has been reported 
[8,13,14,16,23].  The  first  signs  of  manifestation  of 
the disease are generally observed at about 2 years 
of age, followed by accelerated growth from 8 to 9 
years  and  spontaneous  interruption  after  puberty  [1-
3,5,9,11,12,14-16,24,29,38]. However, Ashraf [1] and 
Kalantar [4] suggested that, as observed from 3 to 7 
years of age, growth might be more active after puberty. 
In addition, the age at recognition of symptoms varies 
according to the severity of the disease and degree of 
deformity. In such cases where the onset of symptoms 
of cherubism occurs after puberty, the time of remission 
of the process is expected to be prolonged [1,3,4]. 
In cases where the clinical symptoms are typical to 
cherubism,  the  final  diagnosis  should  be  based  on 
radiographic findings and histology, because the clinical 
picture of cherubism at initial examination are similar to 
other lesions that cause mandible enlargement, such as 
autosomal dominant osteosclerosis [22].
Dental alterations
Dental alterations associated with cherubism include 
early  exfoliation  of  deciduous  teeth,  impaction  and/
or  displacement  of  teeth  [1,4-14,16,20], which 
radiographically  seem  to  float  in  radiolucent  areas, 
conferring  the  so-called  “floating  tooth  appearance” 
[14,20]. In addition, ectopic tooth eruption, agenesis 
of permanent teeth, mainly of the second and third 
molars [26], due to involution of their germs [14], and 
root  resorption  of  existing  teeth  are  observed  [4,5]. 
These alterations result in malocclusion as well as in 
problems of phonation and swallowing, the latter being 
exacerbated  by  flattening  or  inversion  of  the  palatal 
cleft [1,4-6,8-12,14,16].
Biochemical parameters
With regard to biochemical parameters, serum calcium 
and phosphorus concentrations and TSH, FSH, LH, T4 
and T3 hormone levels are usually within normal limits, 
but alkaline phosphatase levels might be elevated 
[1,5,8,10,11,13-15]. A constant finding in these patients 
is the enlargement of submandibular and cervical lymph 
nodes [5,8,13,14].
Radiography
Radiographically, cherubism is characterized by 
expansive radiolucent, generally multiloculated lesions 
clearly delimited by cortical bone and distributed 
bilaterally in the posterior quadrants of the mandible 
and/or maxilla [6,8,9,12,20]. Bone alterations generally 
starts in the region of the angle and ascending ramus 
of the mandible, continue to the mandibular body, 
displacing the mandibular canal, and in some cases 
extending  to  the  coronoid  process  [1-3,8,14,17,23]. 
Involvement of the condyle is rare [3,4,9,11]. In the 
maxilla,  the  injury  process  starts  in  the  maxillary 
tuberosity  region  [4,5,9,10,14]. When process is 
starting  in  mandible,  maxillary  lesions  manifest  at  a 
later time [14]. In more severe cases, infiltration of the 
orbital  cavities  may  cause  exacerbated  exophthalmia 
and limiting ocular movements [1,11,15,16,39].
The lesions of cherubism can be classified according 
to  their  extent:  grade  I,  bilateral  involvement  of  the 
ascending ramus of mandible; grade II, bilateral 
involvement of the ascending ramus of mandible and 
maxillary tuberosity; grade III, complete involvement 
of the maxilla and mandible compromising the coronoid 
processes and condyles [1,4,16].
Radiographically  identified  multilocular  radiolucent 
lesions mainly are affecting the body and ascending 
ramus of the mandible. The coronoid process might 
be  involved  [23,24]  and  the  condition  extends  to 
the maxilla, preferentially to the region of maxillary 
tuberosity  [20,23]. The radiolucencies are mainly 
bilateral and may affect the lower portion and fundus 
of the orbit which cortical bone appears to be thin but 
intact. The teeth are found to be displaced and impacted 
and root resorption is observed; the mandibular canal 
is often displaced [1-3,5,8,11,12,14-16,23]. The facial 
sinuses frequently appear to be obliterated, resuming 
their pneumatic function after regression of disease 
activity [5,14]. Some authors have reported involvement 
of the condyles [1,3,4].
Diagnostics
Observed radiographic appearance might be 
confused with other lesions containing giant cells: 
hyperparathyroidism  [5,8,9,18], and/or osteomalacia 
[19]. Regarding the differential diagnosis, it should be 
emphasized that, whereas central giant cell lesions affect 
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tumours rarely involve bone of the maxillomandibular 
complex, in cherubism the lesions are generally bilateral 
and involve both the maxilla and the mandible [3,18].
The radiographic techniques used for the diagnosis of 
suspected cases of cherubism include posteroanterior 
radiography  of  the  jaws  [5,16], orthopantomography 
[1-4,6-9,11,12,14]  and  teleradiography  [3,14,16]. 
Computed tomography is a useful tool for the 
assessment of the damage caused by the process either 
during the analysis of disease progression or during 
surgical planning [3,5,7-9,40]. Advancements in virtual 
three-dimensional reconstruction of anatomic structures 
based on computed tomography or cone beam computed 
tomography data can provide for more predictable 
individual treatment planning [41]. According to Mnari 
et al. [42] magnetic resonance imaging is useful for 
identifying orbital involvement.
Similarity with central giant cell lesions and 
hyperparathyroidism is also present in the histological 
findings. As observed in these conditions, in cherubism 
multinucleated giant cells are found scattered throughout 
collagenous  and  vascularized  fibrous  connective 
tissue with the observation of dense connective tissue 
which might be highly or poorly cellularized and 
contain a smaller or larger number of collagen fibbers, 
respectively, depending on the progression of the 
lesion  [1,3-8,11,14]. This connective tissue is richly 
vascularised and mainly located around giant cells, with 
the possible presence of bone spicules and hemosiderin 
deposits [1,3-5,7,8,11-16,18]. It is believed that these 
giant  cells  have  osteoclast  activity  [5,13]. Southgate 
et al. [13] found that multinucleated cells in cherubic 
lesions had phenotypic characteristics of osteoclasts, 
resorbing bone in vitro. The specific histological finding 
of cherubism is the presence of eosinophilic perivascular 
cuffing which, however, is not always present [3,14,24] 
and histology is of limited diagnostic significance [26].
Figures  1  to  4  shows  the  extraoral  clinical  and 
radiographic features of two boys (7 and 9 years old) 
with cherubism involving the angle and ascending 
ramus of the mandible. The cases were retrieved from 
the archives of the Discipline of Stomatology, São José 
dos Campos Dental School, UNESP. Figures 5 and 6 
refer to the follow-up of the case shown in Figures 3 and 
4 at nine years after diagnosis.
Laboratory tests contribute to the characterization 
of disease since hematological parameters such 
as calcium and phosphorus are normal and only 
alkaline  phosphatase  levels  might  be  elevated  [1-
3,5,6,8,11,13,15,23]. According to George et al. [3], the 
increase in alkaline phosphatase can be explained by the 
phase of development in most individuals affected by 
the disease. In contrast, in hyperparathyroidism serum 
calcium and PTH levels are increased and phosphorus 
levels are found to be normal or reduced [15,19].
Cytogenetic and molecular studies have being used 
on cherubism diagnostic, such as fluorescence in situ 
hybridization  and  quantitative  analysis  of  Msx-1 
expression in different tissues [26].
Treatment
Once the diagnosis is established, therapeutic 
management should be evaluated. Treatment options 
include waiting for stabilization and spontaneous 
remission  of  the  disease,  tooth  extraction  in  areas 
showing  fibrous  alterations,  cosmetic  osteoplasty  of 
the affected jaws after regression of disease activity 
or, in the case of functional impairment, curettage of 
the lesions and treatment with calcitonin [32,34,43,44]. 
The policy of waiting for disease regression, followed 
by the evaluation of physiological bone remodelling, 
is  the  most  recommended  [3,5-8,11,12,14-16,23,26]. 
However, it is still uncertain whether this approach is 
the most effective one since only a few cases of long-
term follow-up have been reported and in most cases 
submitted to curettage or jaw osteoplasty surgery was 
indicated early [1,3-5,17]. Curettage has been suggested 
to be as a good approach since this intervention 
stimulates  bone  replacement  [3]. However, in his 
original study Jones [17] treated two boys by bilateral 
curettage and one girl was submitted to curettage on 
one  side  and  multiple tooth  extractions on  the other 
side, with no difference in outcome being observed 
between the two sides. According to the author, this 
finding might indicate that cherubism is associated with 
odontogenesis and multiple extractions would resolve 
the case. There is general agreement that in extreme 
cases in which important functions are impaired, 
surgical intervention should be performed as early as 
possible [4,5,8,11,14,19]. Radiation therapy has been 
abandoned as a treatment of cherubism because of the 
potential risk of osteoradionecrosis or even malignant 
transformation of the process resulting in osteosarcoma 
[2,5,8,10,27]. When possible, follow-up is always a 
valuable choice [26].
According to Novack and Faccio [27], hypotesis that 
cherubism is caused by enhanced cytokine tumour 
necrosis  factor  α  (TNF-α)  production  by  myeloid 
cells due to an activating mutation in Sh3bp2 not only 
represents a major advancement in the understanding 
of the disease but suggests new potential options for its 
treatment. Although cherubism was described more than 
70 years ago, the rather sparse literature in this area has 
provided little insight on disease effective therapies. As 
a major pathogenic factor of the identification of TNF-α 
for the patients with this rare disease, is significant news. 
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Figure 1. Photograph of a 7 year old boy with 
cherubism showing bilateral swelling at the 
mandibular angles.
Figure 2. Orthopantomograph of the same patient as in Figure 1. Note the bilateral 
swelling caused by expansion related to multilocular bone lesions of the angle and 
ascending ramus of the mandible and coronoid process.
Figure 3. Photograph of a 9 year old boy with 
cherubism showing bilateral swelling of the 
angle and ascending ramus of the mandible, 
stretching the skin in the nasogenial region.
Figure 4. Orthopantomograph of the same patient as in Figure 3. The image reveals 
bilateral swelling of the angle, ascending ramus of the mandible and coronoid process 
caused by multilocular bone lesions. Note the lack of involvement of the condyles.
Figure 5. Photograph of the same patient 
as in Figure 3 after 9 years of follow-up, 
demonstrating  expressive  progression  of  the 
disease.
Figure 6. Orthopantomograph of the same patient as in Figure 5, revealing radiographic 
alterations characterized by greater radiopacity resulting from bone deposition and 
confirming the lack of involvement of the condylar regions. Note the malpositioning 
and retention of teeth.http://www.ejomr.org/JOMR/archives/2010/2/e2/e2ht.htm    J Oral Maxillofac Res 2010 (Apr-Jun) | vol. 1 | No 2 | e2 | p.6
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the treatment of rheumatoid arthritis. If these drugs will 
prove the effectiveness in the treatment of cherubism it 
can be hoped that the interval from laboratory discovery 
to clinical use would be short [27].
A study by von Wowern [25] followed-up 18 patients 
over the long term and found a significant relationship 
between the grade of cherubism and maximal buccal 
bone expansion, as well as the age for normalization, 
and the grade of cherubism and number of missing 
teeth. Neither patient showed any radiolucencies 
or radiographic signs of sclerotic areas or sclerotic 
thickening of the mandibular ramus. In the same study, 
no larger surgical corrections with removal of the main 
part of the lesional tissue were performed in any of the 
patients. 
A prosthetic treatment for a cherubism patient was 
reported by Yilmaz at al. [28]. The patient’s physical 
appearance showed characteristic cherubic features. 
The  maxillary  canines,  the  second  and  third  molars 
were missing and almost all mandible teeth were 
extracted before the patient was referred for treatment. 
Authors were concerned that implant placement into 
porous bone might result in lack of osseointegration and 
lead to complication. Thus, treatment plan consisted of 
fixed partial dentures preparation for the maxilla and an   
overdenture with copings for the mandible. The patient 
remained satisfied with the function and aesthetic result 
at the one year recall appointment.
CONCLUSIONS
Despite the exceptions, cherubism is a clinically well-
characterized disease which confers to the patient 
the appearance of a baroque cherub; therefore, this 
derived the name of the disease. In cases of a suspicion 
of  cherubism,  radiographic  examination  is  essential 
since the clinical presentation and the location and 
distribution  of  the  lesions  may  define  the  diagnosis. 
Histopathological  examination  is  complementary. 
Nowadays,  genetic  tests  should  be  used  for  final 
diagnosis of cherubism. 
Knowledge of the clinical and radiographic alterations 
observed in patients with cherubism is important since 
the dentist might be the first professional sought for a 
diagnosis of this disease.
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